February 2023

Providers’ and government officials’ perspective of factors affecting human papilloma virus vaccination, cervical cancer screening and treatment in Kampala, Uganda- a qualitative study

Uganda has one of the highest age-standardized cervical cancer (CxCa) incidence rates in Eastern Africa (56.2/100,000 women), due to limited provision and access to CxCa prevention strategies through Human Papillomavirus (HPV) vaccination, CxCa screening and treatment. This study identified barriers and facilitators to HPV vaccination, cervical cancer screening and treatment from CxCa providers’ perspectives in...

Author(s): Kavanya Feustel, Kia Lechleitner, Ronald Anguzu, Simon Kibira, Danielle Savino, Courtney Jankowski, Robert Lukande, Simon Kasasa and Kirsten Beyer  

February 2023

Artemisinins and Artesunate mitigate cytotoxic effects caused by recombinant spike protein of Sars-cov-2

COVID-19 invades human cells with its homotrimer spike glycoprotein (SPK) located in the viral envelope by binding to its target human receptor angiotensin-converting enzyme 2 (ACE2), as well as is responsible for having its own negative physiological and cellular effects. The purpose of this study is to evaluate the impact of SPK on U937 (human histiocytic lymphoma) cells while highlighting the mitigating effects of...

Author(s): Allen Qian, Rian Goding, and Wei Zhu,